Doxepin Hcl
Rank #402 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$22.2M
Total Cost
371,255
Total Claims
$22.2M
Total Cost
13,829
Prescribers
$60
Cost per Claim
31,717
Beneficiaries
505,545
30-Day Fills
$1,602
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$22.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $22.2M total
Top Prescribers of Doxepin Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Walter Perez | Podiatry | Brooklyn, NY | 489 | $388K |
| 2 | Olatunde Osofisan | Podiatry | Brooklyn, NY | 398 | $293K |
| 3 | Eustace Allen | Specialist | Brooklyn, NY | 442 | $284K |
| 4 | Venkata Durbhaka | Podiatry | Bronx, NY | 327 | $226K |
| 5 | Howard Reifer | Podiatry | Brooklyn, NY | 587 | $162K |
| 6 | Karl Cirincione | Podiatry | Brooklyn, NY | 226 | $148K |
| 7 | Sanjay Godhwani | Rheumatology | Wading River, NY | 22 | $142K |
| 8 | Maria Dolgovina | Neurology | Forest Hills, NY | 932 | $117K |
| 9 | Anto Vincetic | Podiatry | Bronx, NY | 175 | $115K |
| 10 | Melvin Hurt | Podiatry | New York, NY | 161 | $113K |
| 11 | Casilda Balmaceda | Neurology | New York, NY | 319 | $109K |
| 12 | Asher Rudowsky | Podiatry | Brooklyn, NY | 153 | $93K |
| 13 | Mohammed Yousuf | Podiatry | Bronx, NY | 937 | $90K |
| 14 | Tamira Vannoy | Podiatry | Brooklyn, NY | 136 | $90K |
| 15 | Sarah Gaballah | Physical Medicine and Rehabilitation | East Hanover, NJ | 310 | $86K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology